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Novel Parameter Estimation Methods for -Acetate
Dual-Input Liver Model With Dynamic PET
Sirong Chen* and Dagan Feng
Abstract—The successful investigation of C-acetate in positron emis-
sion tomography (PET) imaging for marking hepatocellular carcinoma
(HCC) has been validated by both clinical and quantitative modeling
studies. In the previous quantitative studies, all the individual model
parameters were estimated by the weighted nonlinear least squares (NLS)
algorithm. However, five parameters need to be estimated simultaneously,
therefore, the computational time-complexity is high and some estimates
are not quite reliable, which limits its application in clinical environment.
In addition, liver system modeling with dual-input function is very dif-
ferent from the widespread single-input system modeling. Therefore, most
of the currently developed estimation techniques are not applicable. In
this paper, two parameter estimation techniques: graphed NLS (GNLS)
and graphed dual-input generalized linear least squares (GDGLLS) al-
gorithms were presented for C-acetate dual-input liver model. Clinical
and simulated data were utilized to test the proposed algorithms by a
systematic statistical analysis. Compared to NLS fitting, these two novel
methods achieve better estimation reliability and are computationally
efficient, and they are extremely powerful for the estimation of the two
potential HCC indicators: local hepatic metabolic rate-constant of acetate
and relative portal venous contribution to the hepatic blood flow.
Index Terms—Parameter estimation, C-acetate dual-input liver
model.
I. INTRODUCTION
The main focus of positron emission tomography (PET) for the study
of liver diseases remains on the detection of liver tumors [1]–[3]. Re-
cent clinical studies revealed that the detection of hepatocellular carci-
noma (HCC) could be greatly aided by the introduction of 11C-acetate
[3]. The successive quantitative modeling studies have conclusively
shown that the measurement of the local hepatic metabolic rate-con-
stant of acetate (LHMRAct) [4] and the relative portal venous contri-
bution to the hepatic blood flow (av) [5] from the dynamic PET images
can provide important diagnostic information for detecting HCC. In
the previous quantitative studies, all the individual model parameters
were estimated by the weighted nonlinear least squares (NLS) algo-
rithm. However, five parameters need to be estimated simultaneously
[5], which is a difficult task for the weighted NLS. The computational
burden is considerable and some estimates are not quite reliable, which
limits its application in clinical environment. Therefore, statistically re-
liable and computationally efficient algorithms are much desired for the
11C-acetate liver model with dual hepatic blood supply.
Several alternative rapid estimation schemes for the use of dynamic
PET images have been proposed [6]–[9]. The well-known Patlak
method [6] could estimate the LHMRAct. However, the individual
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Fig. 1. Three-compartment C-acetate liver kinetic model with Parameter
in the dual-input function.
parameters are not obtainable, especially av which has superior diag-
nostic value for evaluating HCC. In addition, more accurate estimation
of LHMRAct requires the individual av value rather than the predeter-
mined fixed av value [5]. The integrated projection [7] and the linear
least squares (LLS) methods could provide the estimates efficiently,
however, they are very biased when applied to the clinical PET images
which are noisy and nonuniformly sampled. Although the weighted
integration method [8] is generally applicable in clinical settings, it is
infeasible to predetermine the optimal weighting functions [9]. Feng
et al. [9] proposed an unbiased fast parameter estimation algorithm:
generalized linear least squares (GLLS) for nonuniformly sampled
biomedical system. However, all these techniques are limited in their
clinical application to identify the single-input systems, which are not
applicable for the dual blood supply liver system. In this paper, two
parameter estimation techniques: graphed NLS (GNLS) and graphed
dual-input GLLS (GDGLLS) were proposed. The performance of
these two algorithms was tested by the clinical and simulated data
with comparison to the standard NLS method for the measurement of
LHMRAct, av and all the other individual model parameters.
II. METHODS
The tracer kinetic model describing distribution of labeled 11C-ac-
etate in liver was shown in Fig. 1. In terms of macroparameters, the
observed total tissue time activity cT (t) could be expressed as
cT (t) = (B1 +B2e
 L t)
 cb(t) + HBV  cb(t) (1)
where
B1 =
K1k3
k2 + k3
; B2 =
K1k2
k2 + k3
; L1 = k2 + k3
are the macroparameters, K1 (ml/min/ml), k2 (/min), k3 (/min) are the
rate constants, HBV (ml/ml) is the hepatic blood volume, and 
 de-
notes the operation of temporal convolution [5]. The dual-input func-
tion cb(t) was measured by
cb(t) = (1  av) ca(t) + av  cv(t) (2)
where ca(t) and cv(t) is the tracer concentration in the hepatic artery
(HA) and portal vein (PV), respectively, and av is the “relative portal
venous contribution to the hepatic blood flow” to be estimated. The
LHMRAct was calculated by
LHMRAct =
K1k3
k2 + k3
(3)
which has the same form as the forward clearance K .
Fig. 2. The flow chart of the GNLS estimation procedure.
A. Graphed Nonlinear Least Squares Algorithm
The proposed GNLS approach applied to the 11C-acetate dual-input
liver model has three steps as depicted in Fig. 2. 11C-acetate is metabo-
lized irreversibly with a rate constant of k3 during the scanning period
[4], therefore, beyond the dynamic phase of the dual-input, the ratio of
cT (t) to cb(t) could be described by
cT (t)
cb(t)
=
K
cb(t)
t
0
cb( )d +
K1k2
(k2 + k3)2
+HBV (4)
where
K =
K1k3
k2 + k3
As shown in (1), B1 has the same form as K , therefore, B1 could be
estimated by a graph of the ratio of cT (t) to cb(t) versus the ratio of
the blood tracer concentration time integral to cb(t) during the input
steady-state space (3–10 min). In the first step, B1 was estimated by
this linear graphical analysis. To calculate the dual-input function, av
was empirically set to be 0.8 for the first iteration. During the graphical
fitting period (3–10 min), the two blood time-activity curves (TACs)
are almost virtually identical [10], therefore, the estimated B1 is less
affected by the individual PV contribution ratio (av), and furthermore,
it is well accepted that the linear graphical estimates are very robust
[6]. Therefore, it is reasonable to consider the estimated B1 by step 1
as a prior for the subsequent estimation schemes. In the second step,
the weighted NLS algorithm was utilized to estimateHBV, av and the
other two macroparameters:B2 andL1 with the knownB1, which aims
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Fig. 3. The flow chart of the GDGLLS algorithm.
to minimize the weighted residual sum of squares. The weight used in
this step is
wi =
ti
cT (ti)
i = 1; 2; . . . ; 25 (5)
where ti = t0i   t0i 1 is the scanning interval and cT (ti) is the total
tracer concentration in tissue at the midtimes of sampling time t0i. As
seen in Fig. 2, the first two steps would not cease until the difference
between the estimated av in step 2 and the initial value of av utilized
in step 1 is less than 0.2. In the successive first step estimation, the ini-
tial value of av would be set to the latest estimated av . For nontumor
cases, the iteration generally would not be repeated; for tumor cases,
one more iteration is generally needed. In the third step, K would be
estimated by graphical analysis using the most updated av and the fit-
ting period was 3–10 min. By GNLS method, estimates of HBV, av
and K (LHMRAct) were obtained directly and the model rate constant
parameters K1   k3 were calculated by
K1 =K +B2
k2 =
B2L1
K +B2
k3 =
KL1
K +B2
(6)
Fig. 4. Correlation of the estimated (a) , (b) , (c) , (d)HBV, (e)
and (f) for the eight clinical ROIs by using GNLS and NLS methods.
B. Graphed Dual-Input Generalized Linear Least Squares Algorithm
The first step of the GDGLLS algorithm is the same as the first step
GNLS estimation. The model expressed by the second-order differen-
tial equation is
d2cT (t)
dt2
= HBV 
d2cb(t)
dt2
+ [K1 + (k2 + k3)HBV]

dcb(t)
dt
+K1k3  cb(t)  (k2 + k3)
dcT (t)
dt
(7)
Substitute cb(t) in the first term of (7) with (2) and assume the initial
conditions were all zeros, we obtain
cT (t) = P0  ca(t) + P3 (cv(t)  ca(t)) + P1
t
0
cb( )d
+KP2
t
0
t
0
cb()d
2
  P2
t
0
cT ()d (8)
where
P0 =HBV
P1 =K1 + (k2 + k3)HBV
P2 = k2 + k3
P3 =HBV  av
K =
K1k3
k2 + k3
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Discretize (8) at the midtimes of sampling, the linear equation in matrix
form is
y = X +  (9)
where y = [cT (t1); cT (t2); . . . ; cT (t25)]T ,  = [P0; P1; P2; P3]T are
the parameters to be estimated,  = [1; 2; . . . ; 25]T are the equation
noise, and X is the coefficient matrix. Assume K^ ! K; a^v ! av ,
then the equation at bottom of page holds, where K^ was provided by
step 1 and c^b( ) was calculated by (2) with a^v (the initial guess of av ).
In the second step, the parameters were estimated by
^GDLLS = (X
T
X) 1XT y (10)
where ^GDLLS represents the estimated  in this GDLLS sense. With
the estimatedK by step 1 and the estimates ofP0 P3 by (10),K1 k3,
HBV and av could be obtained.
The estimation results of step 2 would be used as the initial values
of step 3 aiming to refine the fitting results. If all cb(t) terms were
substituted by (2), the 11C-acetate dual-input model could be described
by
d2cT (t)
dt2
=P0 
d2ca(t)
dt2
+ P0av
d2cv(t)
dt2
 
d2ca(t)
dt2
+ P1 
dca(t)
dt
+ P1av
dcv(t)
dt
 
dca(t)
dt
+KP2  ca(t) +KP2av (cv(t)  ca(t))
  P2 
dcT (t)
dt
(11)
where
P0 =HBV
P1 =K1 + (k2 + k3)HBV
P2 = k2 + k3
K =
K1k3
k2 + k3
To obtain the GDGLLS solution, assume K^ ! K and P^0 !
P0; P^1 ! P1; P^2 ! P2 in the second, fourth, and sixth terms of (11),
respectively, we have
d2cT (t)
dt2
=P0 
d2ca(t)
dt2
+ P1 
dca(t)
dt
+ K^P2  ca(t)
+ av P^0
d2cv(t)
dt2
 
d2ca(t)
dt2
+ P^1
dcv(t)
dt
 
dca(t)
dt
+K^P^2 (cv(t)  ca(t))
  P2 
dcT (t)
dt
(12)
where K^ is the estimate by step 1 and P^0; P^1; and P^2 represent the most
updated estimates of P0; P1; and P2, respectively. Take the Laplace
transform of the above equation with the assumption that the initial
conditions were all zeros, whiten the correlated equation errors with an
autoregressive filter s(s + P^2) [9], and then take the inverse Laplace
transform, we obtain
cT (t)  P^2 1 
 cT (t)
= P0 ca(t)  P^2 1 
 ca(t) + P1 1 
 ca(t)
+ P2 K^ 2 
 ca(t)   1 
 cT (t)
+ av P^0 (cv(t)  ca(t)) + (P^1   P^0P^2) 1

(cv(t) ca(t))+K^P^2 2
(cv(t) ca(t)) (13)
where
 1 = e
 P^ t
;  2 =
1
P^2
1  e P^ t
Discretize (13) at the midtimes of sampling, we get
r = Z (14)
where r is the filtered output,  = [P0; P1; P2; av]T are the parameters
to be estimated, and Z is the coefficient matrix. In the third step, the
parameters would be estimated by
^GDGLLS = (Z
T
Z) 1ZT r (15)
where ^GDGLLS represents the estimated  in this GDGLLS sense.
The weight used in (15) was by (5) as well. The termination criterion
for (15) was that either maximum iteration of 10 was reached or the
Euclidean norm of difference of estimates between two successive it-
erations was less than 0.0001. The flow chart of the GDGLLS algo-
rithm was illustrated in Fig. 3. In the fourth step, Parameter K would
be estimated by the graphical analysis with the most updated av and
the fitting period was 3–10 min.
C. Clinical and Simulation Studies
The clinical image acquisition sequences were as follows: ten frames
of 4 s each, eight frames of 10 s each, two frames of 30 s each, followed
by three frames of 60 s each and two frames of 120 s each, a total of 25
frames for 10 min. Six patients including two with HCC were studied.
X =
ca(t1)
t
0
c^b()d K^
t
0
t
0
c^b()d
2
 
t
0
cT ()d (cv(t1)  ca(t1))
ca(t2)
t
0
c^b()d K^
t
0
t
0
c^b()d
2
 
t
0
cT ()d (cv(t2)  ca(t2))
.
.
.
ca(t25)
t
0
c^b()d K^
t
0
t
0
c^b()d
2
 
t
0
cT ()d (cv(t25)  ca(t25))
Authorized licensed use limited to: Hong Kong Polytechnic University. Downloaded on June 25,2010 at 03:45:12 UTC from IEEE Xplore.  Restrictions apply. 
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, VOL. 53, NO. 5, MAY 2006 971
TABLE I
PARAMETER ESTIMATES OF , , , HBV, , AND BY NLS AND GNLS METHODS FOR THE CLINICAL DATASETS
TABLE II
COMPARISON OF THE CVS OF THE ESTIMATED , , , HBV, AND BY NLS AND
THE ESTIMATED , , , HBV, AND BY GNLS FOR THE CLINICAL DATASETS
For each patient, one nontumor region-of-interest (ROI) in liver was ex-
tracted. Two HCC ROIs were extracted from the two patients suffered
from HCC. To obtain the hepatic dual inputs on the dynamic PET im-
ages, the TAC of PV was evaluated by direct activity-time measurement
and the TAC of HA was approximated by evaluating the TAC of the ab-
dominal aorta adjacent to the liver. To reduce the radioactivity spillover
effect from the adjacent tissue, the last five measurements of the TAC
of PV were replaced by the corresponding HA data in this study.
All the parameter estimation methods including NLS, GNLS and
GDGLLS were tested by computer simulated data. Two simulated
datasets (one representing HCC) with the same image-derived dual
inputs extracted from clinical data were generated according to (1). A
pseudorandom number generator was used to generate the Gaussian
noise added to the calculated TAC and the variance structure is

2(ti) =
  cT (ti)
ti
i = 1; 2; . . . ; 25 (16)
where cT (ti) is the calculated TAC, ti is the scanning interval (same
as clinical study), and  is the proportional constant representing the
noise level.
TABLE III
AICS AND SCS BY NLS AND GNLS ALGORITHMS FOR
THE CLINICAL DATASETS
D. Statistical Criteria
For the clinical datasets, the correlation analysis was conducted for
the estimated K1   k3, av , HBV and K provided by NLS and GNLS
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TABLE IV
ESTIMATION RESULTS OF , , , HBV, , AND FROM TWO SETS OF SIMULATION. THE TRUE VALUE OF THE TWO DATASETS IS = 0 65, = 0 40,
= 0 15, HBV = 0 30, = 0 75, AND = 1 35, = 0 35, = 0 13, HBV = 0 30, = 0 40 (REPRESENTING HCC), RESPECTIVELY.
THE ESTIMATED PARAMETERS REPRESENT THEIR MEAN VALUES. THE MEAN VALUES, (PERCENTAGE VALUE),
AND CVs (PERCENTAGE VALUE) WERE CALCULATED FROM 200 SIMULATION RUNS
methods, and additionally the Akaike information criteria (AIC) [11]
and Schwarz criteria (SC) [12] were utilized to test the “goodness of
fit.” The reliability of parameter estimation was accessed by the coef-
ficient of variation (CV) formulated as
CVP =
SDP
P
 100% (17)
where P is the parameter estimate and SDP is the standard deviation
(SD) of P . For clinical study, SDs were estimated as the square roots
of the diagonal elements of the covariance matrix and the covariance
matrix was estimated based on sensitivity functions. For the simulation
study, the accuracy of the estimated parameters was evaluated by bias.
III. RESULTS AND DISCUSSION
To evaluate the performance of GNLS, comparison between the es-
timation by NLS and GNLS for clinical datasets was conducted. The
parameter estimates of K1   k3, HBV, av , and K (LHMRAct) by
NLS and GNLS were listed in Table I. In Table I, the estimation results
TABLE V
AVERAGE NUMBER OF ITERATIONS NEEDED BY
GDGLLS IN SIMULATION STUDY
predicted by the two methods are comparable with each other. The cor-
relation coefficients by correlation analysis of the two sets of K1, k2,
k3,HBV, av , and K (LHMRAct) are 0.9872, 0.9563, 0.9868, 0.9920,
0.9987, and 0.9847, respectively, and the correlation was plotted in
Fig. 4. As shown in Fig. 4, all the estimated parameters by the two ap-
proaches correlated closely with each other. For the six nontumor ROIs,
the estimated av expressed as mean  SD are 0.8495  0.0752 and
0.8361  0.0790 by GNLS and NLS methods, respectively; whereas
the estimatedK by GNLS and NLS methods are 0.1602 0.0225, and
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0.1437  0.0224, respectively. The CVs of the estimated K1, k2, k3,
HBV, and av by NLS and the estimated K , B2, L1, HBV, and av by
GNLS for the clinical datasets were summarized in Table II. The av-
erage CVs of K , B2, and L1 are much less than the mean CVs of K1,
k2 and k3 by NLS (referred to Table II).K1 k3 were calculated by (6)
with the estimated K , B2, and L1, therefore, they could be much more
reliably estimated by the proposed GNLS method. It is worth noting in
Table II that the majority of the CVs of the estimated av by GNLS are
less than those by NLS, and the estimated av of region 8 is considerably
more reliable. The estimation ofHBV by GNLS is generally more reli-
able than that by NLS especially for region 8. As displayed in Table III,
compared to NLS method all SCs by GNLS except those of regions 1
and 7 are smaller, indicating that GNLS could provide better fit. The
two sets of AICs are comparable with each other. During the GNLS fit-
ting, owing to the reduced number of parameters to be estimated by the
recursive NLS procedure, the computational burden is reduced. Since
B1 are predetermined and considered as a prior, the fitting results of
the second step regression are less affected by the initial guess.
The estimation results of K1   k3, HBV, av , and K (LHMRAct)
calculated from 200 simulation runs by NLS, GNLS, and GDGLLS
were presented in Table IV. When compared with NLS method,
K1 k3 could be considerably more reliably estimated by both GNLS
and GDGLLS especially when the noise level is high. Nevertheless,
NLS could provide more accurate estimates of K1   k3. As shown in
Table IV, the estimation of av andHBV by the two proposed methods
is moderately more reliable than that by NLS. The accuracy of the
estimated av and HBV by using the two presented approaches is in
general comparable with that of NLS. In Table IV, the estimation of K
by both GNLS and GDGLLS is much more reliable than that by NLS
for all the cases, especially when the noise level is 2. The estimation
accuracy of K by the two methods is satisfactory since all biases are
around 1% for dataset 1 and less than 1% for dataset 2. When the noise
level is 2, both methods could achieve better fitting accuracy than
NLS for K . It could be seen in Table IV that the estimation accuracy
of all the parameters by the two presented techniques is generally not
sensitive to the noise level, which may be extremely useful in clinical
settings whose noise level is generally high. When comparing the
CV s in Tables II (clinical study) and IV (simulation study), simulated
data with noise level 2 seems comparable with the clinical data. All
the individual model parameters could be expressed analytically in
terms of the PET measurements by GDGLLS algorithm, therefore this
fitting procedure is very fast. The average number of iterations needed
for step 3 of GDGLLS is generally less than 4 (referred to Table V).
As shown in Table V, when the noise level increases, the number of
iterations needed would not increase which may be very valuable in
clinical noisy environment.
IV. CONCLUSION
Two novel parameter estimation techniques for 11C-acetate dual-
input liver model using dynamic PET images were presented in this
study. Compared to NLS approach, more reliable parameter estimates
and better fitting quality in terms of SC could be provided by GNLS
method for clinical study, and the computational burden of GNLS is re-
duced. GDGLLS algorithm could generally identify all the parameters
more reliably than NLS and the fitting procedure is very fast. Compared
to NLS fitting, both presented algorithms could achieve a comparable
estimation accuracy of the two HCC indicators. When the noise level is
2, both methods could even achieve better fitting accuracy ofK . There-
fore, in addition to the robustness and computational efficiency, the two
estimation algorithms could provide better ways for the early detection
of HCC.
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